{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:01Z","timestamp":1707524581314},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,10]]},"DOI":"10.7759\/cureus.25822","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T14:17:23Z","timestamp":1654870643000},"source":"Crossref","is-referenced-by-count":0,"title":["Delayed Diagnosis of Osteogenesis Imperfecta: A Differential Diagnosis Guided by Competing Ocular Findings and a Lack of Family History"],"prefix":"10.7759","author":[{"given":"Eric B","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica Y","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle I","family":"Malwane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Trejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 R","family":"Cucal\u00f3n-Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-007-0023-z","article-title":"Osteogenesis imperfecta: epidemiology and pathophysiology","volume":"5","author":"Martin E","year":"2007","unstructured":"Martin E, Shapiro JR. Osteogenesis imperfecta: epidemiology and pathophysiology. Curr Osteoporos Rep. 2007, 5:91-7. 10.1007\/s11914-007-0023-z","journal-title":"Curr Osteoporos Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ocl.2018.10.003","article-title":"Osteogenesis imperfecta: a pediatric orthopedic perspective","volume":"50","author":"Franzone JM","year":"2019","unstructured":"Franzone JM, Shah SA, Wallace MJ, Kruse RW. Osteogenesis imperfecta: a pediatric orthopedic perspective. Orthop Clin North Am. 2019, 50:193-209. 10.1016\/j.ocl.2018.10.003","journal-title":"Orthop Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1177","article-title":"RNA protein interactions governing expression of the most abundant protein in human body, type I collagen","volume":"4","author":"Stefanovic B","year":"2013","unstructured":"Stefanovic B. RNA protein interactions governing expression of the most abundant protein in human body, type I collagen. Wiley Interdiscip Rev RNA. 2013, 4:535-45. 10.1002\/wrna.1177","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"ref4","unstructured":"Conjunctival pigmented lesions. diagnosis and management. (2013). Accessed: February 2, 2022: https:\/\/www.aao.org\/eyenet\/article\/conjunctival-pigmented-lesions-diagnosis-managemen."},{"key":"ref5","unstructured":"Ocular melanocytosis (melanosis oculi). (2019). Accessed. March 6, 2022: http:\/\/www.eyerounds.org\/atlas\/pages\/Ocular-Melanocytosis\/index.htm."},{"key":"ref6","article-title":"Patient safety, professionalization, and reimbursement as primary drivers for national medical interpreter certification in the United States","volume":"5","author":"Arocha IS","year":"2013","unstructured":"Arocha IS, Joyce L. Patient safety, professionalization, and reimbursement as primary drivers for national medical interpreter certification in the United States. IJTIS. 2013, 5:127-142. 105201.2013.a07","journal-title":"IJTIS"},{"key":"ref7","unstructured":"The National Board for Certification of Medical Interpreters Registry. (2022). Accessed. June 5, 2022: https:\/\/www.certifiedmedicalinterpreters.org\/search-cmi-registry."},{"key":"ref8","unstructured":"Certification Commission for Healthcare Interpreters Registry. (2022). Accessed. June 5, 2022: https:\/\/cchi.learningbuilder.com\/Search\/Public\/MemberRole\/Registry."},{"key":"ref9","unstructured":"United States Census Bureau American Community Survey 5-Year Estimates Tables. S1601 Languages Spoken at Home. (2020). Accessed: June 5, 2022: http:\/\/htthttps:\/\/data.census.gov\/cedsci\/table?q=United%20States&d=ACS%205-Year%20Estimates%20Subject%20Tables&tid=AC...."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2012.01.025","article-title":"Errors of medical interpretation and their potential clinical consequences: a comparison of professional versus ad hoc versus no interpreters","volume":"60","author":"Flores G","year":"2012","unstructured":"Flores G, Abreu M, Barone CP, Bachur R, Lin H. Errors of medical interpretation and their potential clinical consequences: a comparison of professional versus ad hoc versus no interpreters. Ann Emerg Med. 2012, 60:545-53. 10.1016\/j.annemergmed.2012.01.025","journal-title":"Ann Emerg Med"},{"key":"ref11","article-title":"Improving patient education for patients with low literacy skills","volume":"53","author":"Mayeaux EJ Jr","year":"1996","unstructured":"Mayeaux EJ Jr, Murphy PW, Arnold C, Davis TC, Jackson RH, Sentell T. Improving patient education for patients with low literacy skills. Am Fam Physician. 1996, 53:205-11.","journal-title":"Am Fam Physician"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005088.pub3","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","author":"Dwan K","year":"2014","unstructured":"Dwan K, Phillipi CA, Steiner RD, Basel D. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev. 2014, CD005088. 10.1002\/14651858.CD005088.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16101-1","article-title":"Skeletal effects and functional outcome with Olpadronate in children with osteogenesis imperfecta: A 2-year randomised placebo-controlled study","volume":"363","author":"Sakkers R","year":"2004","unstructured":"Sakkers R, Kok D, Engelbert R, et al.. Skeletal effects and functional outcome with Olpadronate in children with osteogenesis imperfecta: A 2-year randomised placebo-controlled study. Lancet. 2004, 363:1427-1431. 10.1016\/S0140-6736(04)16101-1","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.03.013","article-title":"Early bisphosphonate treatment in infants with severe osteogenesis imperfecta","volume":"149","author":"Antoniazzi F","year":"2006","unstructured":"Antoniazzi F, Zamboni G, Lauriola S, Donadi L, Adami S, Tat\u00f2 L. Early bisphosphonate treatment in infants with severe osteogenesis imperfecta. J Pediatr. 2006, 149:174-9. 10.1016\/j.jpeds.2006.03.013","journal-title":"J Pediatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/99500-delayed-diagnosis-of-osteogenesis-imperfecta-a-differential-diagnosis-guided-by-competing-ocular-findings-and-a-lack-of-family-history","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:52Z","timestamp":1707507412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/99500-delayed-diagnosis-of-osteogenesis-imperfecta-a-differential-diagnosis-guided-by-competing-ocular-findings-and-a-lack-of-family-history"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.25822","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,10]]}}}